Columbia, MD, United States of America

Kevin Hall


Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 34(Granted Patents)


Location History:

  • Edmonton, CA (2008)
  • Columbia, MD (US) (2010)

Company Filing History:


Years Active: 2008-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kevin Hall: Innovator in Metabolic Research

Introduction

Kevin Hall is a notable inventor based in Columbia, MD (US), recognized for his contributions to the field of metabolic research. He holds two patents that focus on assessing metabolic substrate utilization and modeling diabetes-related disorders. His work has significant implications for understanding and treating metabolic diseases.

Latest Patents

Hall's latest patents include "Apparatus and methods for assessing metabolic substrate utilization" and "Method and apparatus for computer modeling diabetes." The first patent describes a processor-readable medium that receives data on plasma glucose concentration, plasma free fatty acid concentration, and respiratory quotient. It calculates values of metabolic parameters that indicate a subject's predisposition towards different types of metabolic substrates. The second patent presents a mathematical and computer model of diabetes-related disorders, accounting for complex physiological control mechanisms and predicting the effects of therapeutic interventions.

Career Highlights

Kevin Hall has made significant strides in metabolic research through his innovative patents. His work at Entelos, Inc. has positioned him as a leader in the field, contributing to advancements in understanding metabolic processes and diabetes management.

Collaborations

Hall has collaborated with notable colleagues, including David Polidori and Paul Brazhnik, to further enhance the impact of his research and innovations.

Conclusion

Kevin Hall's contributions to metabolic research through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in understanding and treating metabolic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…